Saturday, December 3, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Directors of Arena Pharmaceuticals inflated the share price by misrepresenting the prospects of their weight-management drug, lorcaserin, or Lorqess, shareholders claim in San Diego Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.